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gation and subsequent differentiation into complex tissue-like 
structures with reproducible ratios of neurons, astrocytes and 
oligodendrocytes. The generated neurons elicit spontaneous 
calcium transients and stimuli-induced neurotransmitter re-
lease. Whole-cell current-and-voltage clamp recordings show 
polarized neurons and voltage-dependent ion currents. Dif-
ferentiated glial cells present astrocytic functions. Moreover, 
expression of genes involved in synaptic and ion transport ma-
chinery and the accumulation of neural proteoglycans suggests 
that this 3D differentiation strategy mimics the neural tissue 
microenvironment better than other differentiation methods. 
These models have applications as tools for preclinical assess-
ment and in disease modelling.
In the next session on reconstituted tissues and 3D bioprint-
ing, Dr Christian Pellevoisin (Episkin Academy, Lyon, France) 
spoke about reconstructed skin, which is a powerful and highly 
versatile technology already used at all stages of cosmetic prod-
uct development (toxicology, UV sensitivity, skin allergy, skin 
aging, skin microbiome, etc). The ability to reproduce several 
functions of human skin in vitro broadens the scope for indus-
trial applications. He demonstrated that it is now possible to pre-
dict positive or negative effects of cosmetics early in their de-
velopment process using in vitro skin models instead of animal 
testing. Reconstructed human skin is also used for screening 
and assessing the efficacy of new active ingredients, decipher-
ing their mechanism of action, and optimizing the composition 
of formulations.
Prof. Mikael Garcia (Poitis, Pessac, France) presented a talk 
on 3D printing. Dealing with tissue complexity and reproducing 
the functional anisotropy of human tissues remains a challenge 
for tissue engineers. Experimental data showing that cell fate is 
controlled by biochemical and/or mechanical cues arising from 
the cell microenvironment suggests that tissue formation obeys 
short range orders without reference to a macroscopic or global 
pattern. In that context, an improved tissue engineering strategy 
might rely on guiding tissue morphogenesis from the cell to the 
tissue level. Laser-assisted bioprinting (LAB) applications so 
far have been limited to biofabrication of thin constructs. Dr 
Garcia now presented an original 3D multimodal and modular 
bioprinter that combines LAB with microvalve bioprinting. 
The 1st INEXO Symposium was hosted on July 7, 2017 in 
Montpellier, France. More than a hundred scientists from eight 
European countries attended. Prof. Gilberte Marti-Mestres 
opened the first symposium expressing his hope that this would 
be the beginning of cycles of such symposia. Ten plenary pres-
entations and four flash talks were given, structured into five 
sessions, “Cellular methods”, “Reconstitution and 3D printing”, 
“Applications”, “Ex ovo models and chronic diseases”, and 
“Organisms (Caenorhabditis elegans and tardigrades) as mod-
els”. A poster exhibition was held at the end of the symposium 
and an award was bestowed on the best poster. Considering the 
current interest in alternative techniques, Prof. Paul Chambon, 
president of the French Society of Pharmacy & Latina Medi-
terranean, has accepted to include an INEXO symposium in the 
program of the XIVth Congress.
In the first session, entitled “Cellular methods”, Dr Romain 
Desprat (Inst. Regenerative Medicine & Biotherapy, Montpel-
lier, France) presented on the “Potential of induced pluripotent 
stem cells (iPSCs) for modeling and treating age-related human 
diseases”. Based on recent technological innovations, it is now 
possible to reprogram somatic cells (usually peripheral blood 
monocytes) into iPSC. He applied this technology to generate 
cellular models of three helicase-linked early aging syndromes. 
He showed that the cells reflected the cellular-related physiol-
ogy and cellular senescence after their differentiation into mes-
enchymal stem cells and their potential derivatives. The iPSC 
lines will allow the study of the cellular and molecular mecha-
nisms linked to senescence and genomic instability pathologies 
of premature aging syndromes for the first time and can be used 
to screen for potential therapeutic compounds to correct the cel-
lular dysfunction.
Prof. Catarina Brito (Instituto de Biologia Experimental 
e Tecnológica, Oeiras, Portugal) explained that the demand 
for robust and predictive human in vitro models is steadily 
increasing. Neural cell fate and functionality are highly regu-
lated processes in which the microenvironment plays a crucial 
role. Alterations of such processes can lead to abnormal neu-
ral development and function and to degeneration. She uses 
perfusion stirred-tank bioreactors to achieve 3D neural differ-
entiation. This strategy induces neural progenitor cell aggre-
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use of the CAM in the context of tumor angiogenesis and metas-
tasis studied during the chick immune incompetent period. New 
blood vessels penetrated the tumor after 72 h implantation and 
favored its rapid growth. The CAM is also used to study tumor 
invasion of the epithelium and the mesenchymal connective tis-
sue, where it forms a dense bed of blood vessels.
Dr Pascal De Santa Barbara (Inserm, Montpellier, France) 
spoke on “Avian retroviral transgenesis approaches: gain & loss 
of function”. The embryonic chick provides an excellent mod-
el system for studies of developmental biology. The model is 
used to target the digestive musculature layer after injection of 
avian retrovirus in an early stage of egg development. Replica-
tion competent avian leukokosis virus long terminal repeat with 
a splice acceptor (RCAS) is a replication-competent retroviral 
vector system that allows in ovo sustained misexpression of a 
gene of interest. RCAS is a modified version of an avian Rous 
sarcoma virus and has been used in gain- and loss-of-function 
approaches to identify key signaling pathways and factors in-
volved in organ and tissue development. Advantages and limita-
tions of the RCAS approaches were discussed.
The last session entitled “Organism models” started with Dr 
Florence Solari (Institute NeuroMyoGene, CNRS UMR5310, 
Inserm U1217, Université Claude Bernard, Villeurbanne, 
France), who presented the role of the transcription factor 
UNC-120/SRF in aging and lifespan of C. elegans. Since mus-
cle deterioration compromises life quality during aging, the 
time course of muscle aging at the subcellular and physiologi-
cal levels in C. elegans was analysed. A dramatic decrease in 
the expression of genes encoding proteins required for muscle 
contraction, followed by a change in mitochondria morphol-
ogy, and an impairment of muscular autophagy was observed. 
It could be demonstrated that the conserved transcription fac-
tor UNC-120/SRF controls muscle aging biomarkers indepen-
dently from its effect on lifespan. In daf-2/insulin/IGF1 recep-
tor mutants, which exhibit a delayed appearance of muscle 
aging biomarkers and are long-lived, disruption of unc-120 
accelerated muscle aging but did not shorten lifespan exten-
sion. Overall, the study identified UNC-120/SRF as the first 
transcription factor that controls the pace of muscle aging in a 
cell autonomous manner.
Prof. Michael Wink (Heidelberg University, Institute of 
Pharmacy and Molecular Biotechnology, Heidelberg, Germa-
ny) explained more about the C. elegans model. This nema-
tode shares a high number of genes and regulatory pathways 
that are relevant in the context of diseases and health disorders 
with humans. It is easy to keep hundreds and thousands of 
nematodes with a lifespan of 2-3 weeks. They are ideal sys-
tems to study aging and the effect of drugs on this process. 
A large number of mutants have been developed, which are 
adapted to disease conditions, such as mutants that express 
the Alzheimer protein a-beta or elements of oxidative stress. 
Several mutant or transgenic strains have been made in which 
relevant key enzymes or proteins are tagged with GFP, which 
facilitates the analysis of drug activity. Prof. Wink has stud-
ied the effects of several medicinal plants, nutraceuticals and 
isolated plant secondary metabolites in C. elegans focusing 
Cells can be printed at cell resolution using LAB while the 
biomaterials are printed at a coarser resolution (100 μm) us-
ing microvalve bioprinting. One mm thick 3D constructs can 
be printed with different biomaterial layer thicknesses and with 
multiple cell micropatterns across tissue constructs. Combining 
technologies featuring different resolutions opens new horizons 
for controlling micro- and macro-organization of tissue com-
ponents, and hence for guiding cellular morphogenesis within 
thick 3D tissues. 
In the session on “Applications”, Dr Laurent Lamy (Nestlé 
Skin Health – Galderma R&D, Sophia-Antipolis, France) and 
his team introduced the cellular thermal shift assay (CETSA®), 
which facilitates the direct assessment of target engagement 
within cells and tissues at various stages of drug development. 
The CETSA® method builds on the concept of thermal stabili-
zation of target proteins upon ligand binding in biological sam-
ples. By quantifying the melting temperature and shift induced 
by the ligand, the potency of target engagement can be quan-
tified. For detecting thermodynamic stability using CETSA®, 
drug- or vehicle treated cell lysates or intact cells were heated to 
different temperatures and the target proteins also were detected 
by Western blotting. The data demonstrates that CETSA® can 
assess drug target engagement in intact cells and thus replace 
the low-throughput Western blot with a quantitative, higher 
throughput assay. CETSA® is likely to be applied in many stag-
es of drug development from high-throughput screening assays 
to clinical trials.
Prof. Ana-Maria Fadda (University Cagliari, Italy) ex-
plained that in vitro techniques are used extensively in academ-
ia and industry to assess skin drug penetration and permeation 
because they predict human dermal penetration well, provide 
results quickly, and are time- and cost-saving. Static test cells 
are composed of donor and receiver compartments of differ-
ent size and a diffusional surface. Excised skin specimens are 
sandwiched as a barrier between the two compartments and the 
formulation is applied to the skin surface. The receiver contains 
a fluid that simulates the blood flow; it should closely simulate 
in vivo conditions of permeation and guarantee sink conditions. 
Alcohol, albumin or cyclodextrin are added to the drug if its 
water solubility is low. Drug permeating from the donor to the 
receiver compartment is determined as a function of time by re-
ceptor fluid removal from the sampling port at regular intervals. 
Flow-through cells can be useful when the permeant has very 
low solubility in the receptor medium. A potential disadvantage 
of the in vitro studies is the lack of information regarding effects 
of blood flow on drug permeation.
Prof. Domenico Ribatti (Department of Basic Medical Sci-
ences, University of Bari Medical School, Italy) started off the 
session on “Ex ovo models and chronic diseases” with his lec-
ture on the chick embryo chorioallantoic membrane (CAM). 
The CAM is an extraembryonic membrane which serves as a 
gas exchange surface and its function is supported by a dense 
capillary network. It has been broadly used to study the morpho-
functional aspects of angiogenesis in vivo and to investigate the 
efficacy and mechanisms of action of pro-angiogenic and anti-
angiogenic natural and synthetic molecules. He presented the 
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supportive environment (ex ovo) to recover functional proper-
ties. This work provides a novel method to extend ex vivo stud-
ies of cardiac function.
Prof. Lorena Rebecchi (Università di Modena e Reggio 
Emilia, Dipartimento di Scienze della Vita, Modena, Italy) pre-
sented an emerging alternative model organism for biomedical 
research, the tardigrade (water bear) that survives freezing, high 
temperatures, irradiation, vacuum of outer space, and complete 
desiccation (losing 97% of body water) owing to reversible sus-
pension of its metabolism called anhydrobiosis. This involves a 
DNA –associating protein (Dsup) and specific intrinsically dis-
ordered proteins (TDPs). The next challenge will be to induce or 
engineer complete desiccation tolerance in cells/tissues of des-
iccation sensitive organisms, using the xeroprotectants detected 
in tardigrades. 
We thank all speakers for their contributions to the success of 
the symposium. 
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on finding compounds that exhibit antioxidant and antiaging 
properties and also works on aspects of neurodegenerative 
diseases.
The flash talk session was opened by Dr Nicolas Lebonvallet 
(Laboratoire Intéractions Epitheliums-Neurones, Brest, France). 
His aim was to directly differentiate stem cells derived from the 
neural crest into sensory neurons. He used skin-derived precur-
sor (SKP) cells derived from the neural crest and extracted from 
the skin tissue by enzymatic and mechanical dissociation. These 
cells were used to induce the Wnt and the BMP pathways. After 
differentiation, they acquired a sensory neuron phenotype ex-
hibiting a bipolar neuronal morphology and expressed neuronal 
markers (Brn3a, p75NTR and peripherin, TRPV1 channel).
Dr Josep-Lluís Viladot (Lipotec, S.A.U., Barcelona, Spain) 
communicated on the transference of actives from polymeric 
film (typically used for face masks and eye patches) to skin by 
means of a percutaneous absorption test with porcine skin bi-
opsies. He showed that it is possible to quantify the amount of 
active compound that is present in every skin layer by extraction 
with selective solvents and HPLC analysis. By carrying out test-
ing after different incubation times, the kinetic pattern allowed a 
certain prediction of in vivo results and the possibility of screen-
ing different candidates.
Dr Amanda Finan-Marchi (Inserm U1046 – CHU, Mont-
pellier, France) used the CAM to study ex vivo cardiac function. 
She grafted dissociated cardiomyocytes or pieces of avian (allo-
graft) or mammalian (xenograft) heart fragments that were then 
vascularized by the CAM. The grafts regained functionality as 
evidenced by beating, and stimulation by epinephrine signifi-
cantly enhanced the beat rate frequency of the grafted tissues. 
The results demonstrate that cardiac grafts find a complex and 
